These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13867919)

  • 1. Tests for biologic safety of arlacel A.
    BERLIN BS
    Ann Allergy; 1962 Jul; 20():472-9. PubMed ID: 13867919
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical and biologic properties of Arlacel A. A review.
    BERLIN BS
    Ann Allergy; 1963 Feb; 21():82-90. PubMed ID: 13970872
    [No Abstract]   [Full Text] [Related]  

  • 3. The toxicity of free fatty acids and Arlacel A.
    Hardegree MC; Kirschstein RL
    Ann Allergy; 1968 May; 26(5):259-68. PubMed ID: 5690233
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractionation of Arlacel A.
    Berlin BS; Wyman R
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1363-8. PubMed ID: 5554487
    [No Abstract]   [Full Text] [Related]  

  • 5. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examination of the properties of amphotensides with potential use as pharmaceuticals].
    Bialik W
    Acta Pol Pharm; 1992; 49(1-2):97-101. PubMed ID: 8769083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.
    Miles AP; McClellan HA; Rausch KM; Zhu D; Whitmore MD; Singh S; Martin LB; Wu Y; Giersing BK; Stowers AW; Long CA; Saul A
    Vaccine; 2005 Mar; 23(19):2530-9. PubMed ID: 15752840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of murine influenza A virus pneumonitis by surfactant nano-emulsions.
    Donovan BW; Reuter JD; Cao Z; Myc A; Johnson KJ; Baker JR
    Antivir Chem Chemother; 2000 Jan; 11(1):41-9. PubMed ID: 10693653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE).
    Makinen SR; Zhu Q; Davis HL; Weeratna RD
    Int Immunol; 2016 Sep; 28(9):453-61. PubMed ID: 27055469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes].
    Afonin NI; Rybolovleva IuR; Putiatina TK; Aprosin IuD; Doronina NN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):12-4. PubMed ID: 7178045
    [No Abstract]   [Full Text] [Related]  

  • 11. EMULSIFIED PANTOPAQUE FOR CEREBRAL VENTRICULOGRAPHY.
    MARKESBERY W; WILSON CB
    Surg Forum; 1964; 15():419-21. PubMed ID: 14189442
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal toxicity evaluation of Drakeol-Arlacel mixtures used for allergenic extract emulsions.
    MOLOMUT N; SMITH LW; CENTER JG
    Ann Allergy; 1961 Sep; 19():1010-5. PubMed ID: 14475272
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil.
    Warisnoicharoen W; Lansley AB; Lawrence MJ
    J Pharm Sci; 2003 Apr; 92(4):859-68. PubMed ID: 12661071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is the indiscriminate use of surface-active agents in drugs legal?].
    CALCAGNO L
    Gazz Med Ital; 1962 May; 121():145-6. PubMed ID: 13875681
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of efficacy and safety of various adjuvant formulations with a total soluble extract of Trichinella spiralis.
    Aucouturier J; Deville S; Perret C; Vallée I; Boireau P
    Parasite; 2001 Jun; 8(2 Suppl):S126-32. PubMed ID: 11484335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE FATE OF CHYLOMICRONS IN RATS TREATED WITH TRITON WR-1339.
    Moore WT; Tidwell HC; Mcpherson JC
    Am J Clin Nutr; 1965 Jan; 16():135-40. PubMed ID: 14262109
    [No Abstract]   [Full Text] [Related]  

  • 17. CHARACTERIZED OILS FOR USE IN INTRAVENOUS FAT EMULSIONS.
    Singleton WS
    Am J Clin Nutr; 1965 Jan; 16():16-22. PubMed ID: 14262113
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application.
    Weyenberg W; Filev P; Van den Plas D; Vandervoort J; De Smet K; Sollie P; Ludwig A
    Int J Pharm; 2007 Jun; 337(1-2):291-8. PubMed ID: 17300887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens.
    Stone HD; Brugh M; Hopkins SR; Yoder HW; Beard CW
    Avian Dis; 1978; 22(4):666-74. PubMed ID: 219830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxicity and absorption enhancing ability of surfactants.
    EICKHOLT TH; WHITE WF
    Drug Stand; 1960; 28():154-62. PubMed ID: 13726093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.